[Identifying myocardial ischaemia in diabetics. SFC/ALFEDIAM joint recommendations].
Puel
J
J
Société française de cardiologie.
Valensi
P
P
Vanzetto
G
G
Lassmann-Vague
V
V
Monin
J L
JL
Moulin
P
P
Ziccarelli
C
C
Mayaudon
H
H
Ovize
M
M
Bernard
S
S
Van Belle
E
E
Halimi
S
S
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000150:complications; D023921:Coronary Stenosis / Q000150:complications; D003925:Diabetic Angiopathies / Q000150:complications* / Q000517:prevention & control; D005602:France; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D017202:Myocardial Ischemia / Q000150:complications* / Q000175:diagnosis* / Q000628:therapy; D009204:Myocardial Revascularization; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors